2-Styrylchromones Prevent IL-1β-Induced Pro-Inflammatory Activation of Fibroblast-like Synoviocytes while Increasing

Ana Teresa Rufino1, Mariana Lucas1, Artur M S Silva2

  • 1LAQV, REQUIMTE, Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira No. 228, 4050-313 Porto, Portugal.

Pharmaceutics
|March 29, 2023
PubMed

Insights

This study explored 2-Styrylchromones (2-SC) as potential treatments for rheumatoid arthritis (RA). One specific 2-SC compound effectively reduced inflammation markers and inhibited key pathways involved in RA joint destruction.

Area of Science:

  • Biochemistry and Molecular Biology
  • Immunology
  • Pharmacology

Background:

  • Rheumatoid arthritis (RA) is a chronic inflammatory disease causing joint destruction.
  • Current RA treatments lack efficacy in controlling synovitis and catabolism.
  • 2-Styrylchromones (2-SC) possess known antioxidant and anti-inflammatory properties.

Purpose of the Study:

  • To investigate the anti-inflammatory and anti-catabolic effects of six 2-SC compounds on human fibroblast-like synoviocytes (HFLS).
  • To elucidate the role of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway in the action of 2-SC.

Main Methods:

  • Assessed the impact of 2-SC on interleukin-1β (IL-1β)-induced nitric oxide (NO), inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and matrix metalloproteinase-3 (MMP-3) in HFLS.
  • Analyzed the modulation of the NF-κB pathway, including inhibitor of kappa B alpha (IκBα) and p65 nuclear levels.

Main Results:

  • One specific 2-SC compound significantly reduced NO production and iNOS expression.
  • This 2-SC also decreased MMP-3 protein expression, indicating anti-catabolic effects.
  • The compound inhibited the NF-κB pathway by affecting IκBα and p65 levels, while increasing COX-2 expression.

Conclusions:

  • A specific 2-SC derivative demonstrates significant potential for treating RA by reducing inflammation and cartilage degradation.
  • The compound's mechanism involves the inhibition of the NF-κB pathway.
  • Further research into 2-SC compounds could lead to novel, effective RA therapies.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.6K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
188
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.5K